Home > Boards > US OTC > Delisted >

NMI Health, Inc. (fka NANM)

RSS Feed
Add Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 10/15/2015 9:32:16 AM - Followers: 14 - Board type: Free - Posts Today: 0

Level 2 View - Not Realtime!

 

 

 

 

  Q. What is swine flu?

A. Swine influenza, or flu, is a contagious respiratory disease that affects pigs. It is caused by a type-A influenza virus. Outbreaks in pigs occur year-round.
The most common version is H1N1. The current strain is a new variation of an H1N1 virus, which is a mix of human and animal versions.

 

24 APRIL --Epidemic and Pandemic Alert and Response (EPR)  

 

EMFP .49...this is damn important for EMFP...Itochu is an $85 BILLION Corp-worldwide...they will sell at least thru out Asia...not just Japan...as bird flu is becoming a very real threat over there. This is part 1...part 2 are the results of the military testing due soon...see next PR below this one...the testing is just pro forma IMO...this will be a helluva one two punch and should finally get EMFP moving:

B: Itochu Techno Chemical Obtains Regulatory Approval to Import and Sell Emergen
y Filtration Products' Respiratory Devices in Japan

HENDERSON, Nev., Oct 21, 2004 (BUSINESS WIRE) -- Emergency Filtration Products
Inc. (EFP) (OTCBB: EMFP) today announced that its partner, Itochu Techno
Chemical Inc., has obtained a Certificate of Import and a Certificate of Sale
from Koseisho (the Japanese Ministry of Health and Welfare, akin to the U.S.
FDA) to immediately begin importing and selling EFP's RespAide, Vapor Isolation
Valve and Series One Breathing Circuit Filter products in Japan.

EFP and Itochu Techno Chemical have been collaborating for over 18 months in
order to help bring EFP's products to market in Japan, as well as preparing a
feasibility study to expand distribution to other Asian countries, with possible
global expansion. After filing an application with Koseisho on Feb. 27, 2004,
the two companies began working on a distribution agreement that would govern
the sale of EFP products to Itochu Techno Chemical and other related companies.
EFP expects to enter into a long-term distribution agreement in the near future.

"We are extremely pleased to have our products cleared for launch in Japan,"
said Douglas K. Beplate, president, EFP. "We would like to thank our partners at
Itochu Techno Chemical for all of their hard work with regard to the application
made with Koseisho and especially with respect to their meticulous and
painstaking approach to assuring the success of our products in the Japanese
market place." Beplate went on to add, "EFP is highly confident that Itochu
Techno Chemical's expertise will not only pay off in the rapidly growing $300
million Japanese market for respiratory products, but will also lead to success
in other Asian countries and beyond."

Itochu Techno Chemical (http://www.techno-chemical.com/ is a subsidiary of
Itochu Corp.

Itochu Corp. (http://www.itochu.co.jp/main/index.html), one of the world's
largest trading companies with 2003 revenues in excess of $85 billion, ranked
11th in the world by revenues, according to Forbes magazine. Itochu is a
globally integrated corporation with offices in over 80 countries and operations
that cover a broad spectrum of industries.

About Emergency Filtration Products Inc.

EFP (http://www.emergencyfiltration.com/) is an air filtration products
manufacturer whose patented 2H Technology(TM) filter system has produced
filtration efficiencies of "greater than 99.99%" at a particulate size of 0.027
microns. Its initial products were developed for the medical market: the Vapor
Isolation Valve(TM) and RespAide(R) CPR Isolation Mask used for resuscitation of
respiratory/cardiac arrest cases; and the 2H Breathing Circuit Filter for
ventilators, respirators and anesthesia circuitry. Each has received FDA
approval. The company also markets an Automated External Defibrillator Prep Kit
featuring RespAide; and the NanoMask(R), a nanotechnology enhanced environmental
mask. In addition to filtration products, the company supplies Superstat(R), a
modified hemostatic collagen, to the U.S. military for surgery and extreme wound
care.

B: Center for Commercialization of Advanced Technology -- CCAT --
B: Center for Commercialization of Advanced Technology -- CCAT -- Awards Emergen

HENDERSON, Nev., Sep 14, 2004 (BUSINESS WIRE) -- Emergency Filtration Products,
Inc. (EFP) (OTCBB:EMFP) announces that it has been awarded a Prototype
Development/Testing/Evaluation Grant (PDT&E) to develop a testing protocol for
filter media on behalf of the U.S. Military. As part of this project, EFP will
begin testing its licensed nano-enhanced filter media at Edgewood Chemical
Biological Center in Edgewood, Maryland within the next few weeks. The testing
and evaluation process is expected to take approximately one month to complete,
following which (assuming positive testing results), EFP expects to sub-license
its nano-enhanced filter media to a Department of Defense approved manufacturer
to enhance existing filtration products that are currently used by the U.S. Air
Force, Army and Navy, as well as to commence development of new product
applications that will serve to better protect U.S. Military personnel.

"The award of the PDT&E grant from CCAT to develop a standard filter media
testing protocol for the U.S. Military is a milestone for our company," said
Douglas K. Beplate, President, EFP. "While we originally expected to begin
testing for the U.S. Air Force last month, we have been requested to have our
filter technology tested for all branches of the Military simultaneously." Mr.
Beplate went on to add, "We expect that the testing will not only prove to be
successful, but will also lead to a rapid commercialization of our licensed
nano-enhanced filter media technology which will assist all branches of the U.S.
Military - Army, Air Force and Navy - to incorporate our technology into
applications that will serve the U.S. Military worldwide."

For the past 18 months, EFP has been working in conjunction with U.S. Army
Research, Development & Engineering Command (RDECOM) to test its nano-enhanced
2H filter technology in order to accelerate the commercial development of a
number of filter technology applications and allow for rapid procurement by the
U.S. Department of Defense. RDECOM has been examining how to apply the company's
filter technology to a large number of potential applications, including, but
not limited to: biohazard masks, transportation (aircraft, tanks, armored
personnel carriers) and buildings (military, industrial, office and
residential). The program has conducted a number of cost and user needs
analyses, economic analyses and technical viability studies of EFP's proprietary
licensed 2H Filter technology. Over 1,000 potential applications of EFP's filter
technology have been identified by RDECOM.


About RDECOM:

http://www.rdecom.army.mil/index.html

MISSION -- Get the right integrated technologies into the hands of warfighters
quicker.

VISION -- To be recognized as the preeminent world leader in research,
development and engineering of systems, whose hallmark is transitioning the
right technology in the shortest time to our Soldiers.

INTENT -- The Commanding General of the U.S. Army Materiel Command (AMC)
established the U.S. Army Research, Development & Engineering Command (RDECOM),
as a new major subordinate command within AMC. This new command will restructure
core in-house capabilities now so we can fully exploit the enormous potential
that resides in research activities around the world. RDECOM will respond
rapidly by integrating, maturing and demonstrating emerging technologies to
field the right equipment, in the shortest time, for our Soldiers.


About ECBC:

http://www.ecbc.army.mil/

ECBC is the nation's principal research and development center for chemical and
biological defense. Tracing its roots back to 1917, ECBC leverages more than 85
years of experience with live agent to develop and enhance defense systems.

ECBC seeks opportunities to develop partnerships with industry, academia and
state and local governments to continue achieving major technological advances
for national defense, civilian protection and industrial competitiveness.
Complimenting these efforts, the Center offers several unique facilities that
provide full life-cycle support to chemical and biological protection, detection
and monitoring capabilities.

About CCAT:

The CCAT (http://www.ccatsandiego.org/index.shtml)- supported by Congress and
funded by the Department of Defense - is a public-private collaborative
partnership between academia, industry, and government. Partners include San
Diego State University (SDSU) Foundation and Entrepreneurial Management Center,
the University of California, San Diego (UCSD) Jacobs School and UCSD CONNECT,
and Lockheed Martin ORINCON Technologies, Inc. with support from the Space and
Naval Warfare Systems Center, San Diego. The consortium-style CCAT intends to
bridge the gap that exists between the generators of technology, the Department
of Defense and the commercial marketplace. EFP will also be working in
conjunction with the Office of Technology Transfer and Commercialization (OTTC)
at California State University, San Bernardino (http://ottc.csusb.edu/), a CCAT
partner on this project.

 

PostSubject
#405   NANM revoked: Renee 10/15/15 09:32:16 AM
#403   NANM SEC Suspension for Financials delinquencies: Renee 09/11/15 09:32:25 AM
#402   NMI Health, you must meet your legal obligations--there laker5 10/16/14 09:22:21 PM
#401   OK before investing here you should know that laker5 10/06/14 12:31:09 PM
#400   testing testing laker5 10/06/14 12:28:31 PM
#399   These masks can be used for ebola? custom123 08/05/14 12:25:27 PM
#397   Nice steady climb PennyStockPower 04/28/14 03:09:01 AM
#396   I took a starter today just in case. PennyStockPower 04/16/14 08:12:34 PM
#395   I agree - oh well. Maybe this will aces21 04/16/14 02:38:31 PM
#394   I noticed the website was back a week db7 04/16/14 01:15:40 PM
#393   Nice NathanH 04/16/14 12:34:14 PM
#392   NANM is smells like a winner kranthikumar 02/27/14 09:49:11 AM
#391   decided to look @ this one again to db7 02/25/14 12:36:20 PM
#390   with this company its stock does spike from kingb11 08/21/13 01:01:46 PM
#389   Back to 20 cents before September. My willlbone 08/08/13 04:23:17 PM
#388   now the big question... who is doing all db7 08/08/13 01:48:47 PM
#387   Buying cheap ones today. willlbone 08/08/13 11:57:36 AM
#386   I haven't either, and I'm holding more than Phull1 08/07/13 01:31:35 PM
#385   with the pre-split action it definitely seemed like db7 08/07/13 01:29:56 PM
#384   Yep, same here. This is ridiculous, I Phull1 08/07/13 01:24:17 PM
#383   disgusted. wish i sold pre-split db7 08/07/13 01:22:58 PM
#382   good point.. although before their issues prices seemed db7 07/19/13 04:08:25 PM
#381   They trade it down so they can get dfflbears 07/19/13 03:45:50 PM
#380   They trade it down so they can get dfflbears 07/19/13 03:45:44 PM
#379   now trading (pre-split adjusted) at .015 and bid db7 07/19/13 11:50:18 AM
#378   'may' create demand(?): http://www.washingtonpost.com/national/health-science db7 06/20/13 09:22:15 AM
#377   interesting mention(s): db7 06/20/13 09:21:48 AM
#376   It would be even more impressive if they dfflbears 06/17/13 10:01:34 AM
#375   yep..impressive website and product line imo db7 06/11/13 03:23:54 PM
#374   It is nice to see that they are dfflbears 06/11/13 03:22:43 PM
#373   from today's pr: db7 06/11/13 11:22:46 AM
#372   woot my 650 shares i bought for .30 kingb11 06/05/13 08:07:57 PM
#371   "The number of shares of the Company's issued db7 06/05/13 09:17:52 AM
#370   new website is now up at nmihealth.com db7 06/05/13 09:17:44 AM
#369   NMI to Launch SilverCare Plus® Antimicrobial Performance Fabric db7 06/05/13 09:16:42 AM
#368   Nano Mask Inc., changed to NMI HealthInc., and Renee 06/04/13 05:40:15 PM
#367   new website in development(?): http://www.mithriltest.com/investors db7 05/31/13 09:47:29 AM
#366   The reverse split. Did you read any dfflbears 05/19/13 06:29:00 PM
#365   What did they pre-announce? donttryme 05/18/13 01:18:25 PM
#364   I liked that fact that they pre-announced it. dfflbears 05/18/13 10:48:35 AM
#363   Agreed. I think this will be a db7 05/18/13 08:16:03 AM
#362   With the reverse in place I'm looking for dfflbears 05/17/13 08:45:18 PM
#361   IMO this goes if someone paints the .04s rlwinvestor 04/08/13 02:23:49 PM
#360   Someone is accumulating... and doing it smartly. dfflbears 01/25/13 07:52:52 PM
#359   Nano Mask Names Dr. Hassan Bennani to Board db7 01/24/13 01:20:07 PM
#358   Action of late is nice... maybe some positive dfflbears 01/19/13 06:47:27 AM
#357   I have read the PR. I don't dfflbears 10/25/12 04:56:12 PM
#356   "In total, agreements with the distributor call for db7 10/25/12 03:07:58 PM
#355   Read the pr lol db7 10/24/12 09:02:29 PM
#354   What are the minimum amounts? dfflbears 10/24/12 05:48:13 PM
PostSubject
Consent Preferences